Pure Global AI
HSA · registration DE0504050

Instrumentation Laboratory HemosIL SynthAFax

SingaporeHematologyClass CInstrumentation Laboratory Company
Official record identity
Registration number
DE0504050
Model name
HemosIL Factor Diluent; HemosIL Normal Control ASSAYED; HemosIL Low Abnormal Control ASSAYED; HemosIL High Abnormal Control ASSAYED; HemosIL Calibration Plasma; HemosIL SynthAFax
Model identifier
0009757600; 0020003110; 0020003210; 0020003310; 0020003700; 0020007400
Registration date
January 22, 2020
Classification
Risk class
Class C
Official value: CLASS C
Published category
Hematology
Published parties
Registrant / registration holder
BIOMED DIAGNOSTICS PTE LTD
Official description

Intended for in vitro determination of Activated Partial Thromboplastin Time (APTT) in human citrated plasma on IL Coagulation Systems, for the evaluation of the intrinsic coagulation pathway, APTT substitution test and the monitoring of heparin therapy.

Additional source fields
Product owner address
180 Hartwell Road, Bedford MA 01730, United States of America, United States
Registrant address
18 BOON LAY WAY, #05-105, TRADEHUB 21, Singapore 609966
About this record

This page mirrors one row from HSA’s official registered-medical-device workbook. Product owner and registrant are separate published roles; neither is relabeled as the manufacturer. The official NOT_GENERATED value is retained when HSA does not publish a registration number, and the device name remains part of the stable record identity.